Status:
ENROLLING_BY_INVITATION
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Lead Sponsor:
Seoul National University Hospital
Conditions:
Crohn Disease (CD)
Ulcerative Colitis (UC)
Eligibility:
All Genders
10+ years
Brief Summary
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul...
Eligibility Criteria
Inclusion
- Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.
Exclusion
- Patients diagnosed with cancer or with a history of cancer treatment.
- Participation may be restricted at the discretion of the medical team.
- Infants and young children under the age of 10.
Key Trial Info
Start Date :
January 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT07166588
Start Date
January 20 2021
End Date
December 31 2028
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Seoul, South Korea, 03080